Related Experiment Video
Updated: Jul 11, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Correlation between thrombomodulin and severe preeclampsia: a summary.
1Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. wviroj@yahoo.com
Summary
Elevated thrombomodulin levels are significantly associated with preeclampsia. This finding highlights thrombomodulin as a potential biomarker for severe preeclampsia risk assessment.
Area of Science:
- Biochemistry
- Hematology
- Obstetrics
Background:
- Thrombomodulin is a key protein C pathway cofactor.
- Plasma thrombomodulin levels are influenced by genetic and atherosclerotic risk factors.
- The role of thrombomodulin in preeclampsia is debated.
Purpose of the Study:
- To evaluate the correlation between thrombomodulin levels and preeclampsia.
- To assess thrombomodulin as a potential risk factor for severe preeclampsia.
Main Methods:
- Retrospective analysis of 4 case-control studies.
- Inclusion of 149 patients with preeclampsia and 120 controls.
- Statistical evaluation of thrombomodulin levels and demographic data.
Main Results:
- Significantly higher average thrombomodulin levels in preeclampsia patients (66.7 ng/mL) compared to controls (45.7 ng/mL).
- A strong positive correlation (r=0.96) between population ethnicity and thrombomodulin levels.
- P-values indicate statistical significance for both findings (P < .05).
Conclusions:
- Thrombomodulin levels are significantly elevated in patients with preeclampsia.
- Thrombomodulin may serve as a valuable biomarker for preeclampsia risk.
- Further research is warranted to elucidate the precise role of thrombomodulin in preeclampsia pathophysiology.
